Does ERLOTINIB Cause Metastases to bone? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Metastases to bone have been filed in association with ERLOTINIB (Erlotinib). This represents 0.5% of all adverse event reports for ERLOTINIB.
105
Reports of Metastases to bone with ERLOTINIB
0.5%
of all ERLOTINIB reports
46
Deaths
17
Hospitalizations
How Dangerous Is Metastases to bone From ERLOTINIB?
Of the 105 reports, 46 (43.8%) resulted in death, 17 (16.2%) required hospitalization.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERLOTINIB. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which ERLOTINIB Alternatives Have Lower Metastases to bone Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE